Top Markets
#1 Siren Siren +38.07%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.61%
#3 RedStone RedStone +20.14%
#4 Verus Coin Verus Coin +18.07%
#5 Cysic Cysic +17.41%
#6 Ocean Protocol Ocean Protocol +16.25%
#7 Perle Perle +14.21%
#8 KUB Coin KUB Coin +13.13%
#9 OpenEden OpenEden +12.87%
#10 Arowana Arowana +12.55%
Coin of the day
Siren Siren
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Ainos, Inc. Ainos, Inc.

Ainos, Inc.

AIMD
Kedudukan dalam Saham #32145
Ainos, Inc. operates as a healthcare technology company, specializing in... Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.
Harga Saham
$1.49
Disegerakkan terakhir: 2026-08-17
Modal Pasaran
$10.94M
Perubahan (1 hari)
4.58%
Perubahan (1 tahun)
-55.67%
Negara
US
Perdagangan Ainos, Inc. (AIMD)

Kategori

Healthcare
Pendapatan untuk Ainos, Inc. (AIMD)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Ainos, Inc., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Ainos, Inc. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR